These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25723557)

  • 1. Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
    Marcellin F; Demoulin B; Spire B; Suzan-Monti M; Roux P; Protopopescu C; Sagaon-Teyssier L; Duracinsky M; Dray-Spira R; Carrieri MP;
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):701-13. PubMed ID: 25723557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life of people living with HIV followed up in hospitals in France: comparing trends and correlates between 2003 and 2011 (ANRS-VESPA and VESPA2 national surveys).
    Douab T; Marcellin F; Vilotitch A; Protopopescu C; Préau M; Suzan-Monti M; Sagaon-Teyssier L; Lert F; Carrieri MP; Dray-Spira R; Spire B;
    AIDS Care; 2014; 26 Suppl 1():S29-40. PubMed ID: 24731158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using patient-reported outcomes to improve the management of co-infection with HIV and HCV: the ANRS CO13 HEPAVIH cohort.
    Marcellin F; Roux P; Winnock M; Lions C; Dabis F; Salmon-Ceron D; Loko MA; Spire B; Carrieri MP
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):351-8. PubMed ID: 24580042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.
    Molina JM; Orkin C; Iser DM; Zamora FX; Nelson M; Stephan C; Massetto B; Gaggar A; Ni L; Svarovskaia E; Brainard D; Subramanian GM; McHutchison JG; Puoti M; Rockstroh JK;
    Lancet; 2015 Mar; 385(9973):1098-106. PubMed ID: 25659285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.
    Stenkvist J; Weiland O; Sönnerborg A; Blaxhult A; Falconer K
    Scand J Infect Dis; 2014 Sep; 46(9):624-32. PubMed ID: 24984040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
    PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and correlates of emotional distress in HIV/HCV coinfection.
    Pereira M; Fialho R; Canavarro MC
    AIDS Care; 2014; 26 Suppl 1():S56-64. PubMed ID: 24720733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.
    Krastinova E; Bani-Sadr F; Fromentin D; Goujard C; Hessamfar M; Yazdanpanah Y; Pol S; Cacoub P; Perronne C; Carrat F
    J Infect; 2014 May; 68(5):462-6. PubMed ID: 24378283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey).
    Marcellin F; Lorente N; Demoulin B; Carrieri MP; Suzan-Monti M; Roux P; Lert F; Sagaon-Teyssier L; Dray-Spira R; Spire B;
    Sex Transm Infect; 2015 Feb; 91(1):21-3. PubMed ID: 25096920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reduced factor structure for the PROQOL-HIV questionnaire provided reliable indicators of health-related quality of life.
    Lalanne C; Chassany O; Carrieri P; Marcellin F; Armstrong AR; Lert F; Spire B; Dray-Spira R; Duracinsky M
    J Clin Epidemiol; 2016 Apr; 72():116-25. PubMed ID: 26548542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.
    Reiberger T; Obermeier M; Payer BA; Baumgarten A; Weitner L; Moll A; Christensen S; Köppe S; Kundi M; Rieger A; Peck-Radosavljevic M
    Antivir Ther; 2011; 16(6):815-24. PubMed ID: 21900713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
    Winnock M; Bani-Sadr F; Pambrun E; Loko MA; Carrieri P; Neau D; Morlat P; Marchou B; Dabis F; Salmon D;
    HIV Med; 2013 Aug; 14(7):430-6. PubMed ID: 23461846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study.
    Préau M; Marcellin F; Carrieri MP; Lert F; Obadia Y; Spire B;
    AIDS; 2007 Jan; 21 Suppl 1():S19-27. PubMed ID: 17159583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short article: Anger and quality of life in patients co-infected with HIV and hepatitis C virus: a cross-sectional study (ANRS CO13-HEPAVIH).
    Marcellin F; Protopopescu C; Esterle L; Wittkop L; Piroth L; Aumaitre H; Bouchaud O; Goujard C; Vittecoq D; Dabis F; Salmon-Ceron D; Spire B; Roux P; Carrieri MP;
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):786-791. PubMed ID: 28418984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
    Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ
    AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV).
    Abbas M; Patrizia C; Fabienne M; Marc B; Lucia P; Fabrice C; Martin D; Camelia P
    Qual Life Res; 2024 Jun; 33(6):1527-1540. PubMed ID: 38580786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of factors influencing health-related quality of life in HIV-infected patients.
    Briongos Figuero LS; Bachiller Luque P; Palacios Martín T; González Sagrado M; Eiros Bouza JM
    HIV Med; 2011 Jan; 12(1):22-30. PubMed ID: 20497251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient.
    Rodríguez-Torres M
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1117-28. PubMed ID: 23199398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
    Marcellin F; Di Beo V; Aumaitre H; Mora M; Wittkop L; Duvivier C; Protopopescu C; Lacombe K; Esterle L; Berenger C; Gilbert C; Bouchaud O; Poizot-Martin I; Sogni P; Salmon-Ceron D; Carrieri P;
    J Hepatol; 2020 Mar; 72(3):588-591. PubMed ID: 31924411
    [No Abstract]   [Full Text] [Related]  

  • 20. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
    Barré T; Mercié P; Lions C; Miailhes P; Zucman D; Aumaître H; Esterle L; Sogni P; Carrieri P; Salmon-Céron D; Marcellin F;
    AIDS Res Ther; 2022 Mar; 19(1):15. PubMed ID: 35292069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.